Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thatcher

Showing results (121-130 of 289) with videos related to

Pageof 29
Sort By:
Clinical Transplantation|April 1, 1995
Primary varicella in adult renal transplant recipients: a report of three cases plus a review of the literatureA P Parnham, J P Flexman, B M Saker, et al.
Developmental Neuroscience|January 1, 1993
Studies on metabolic regulation using NMR spectroscopyH Bachelard, R Badar-Goffer, O Ben-Yoseph, et al.
International Journal of Immunopharmacology|January 1, 1982
Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patientsN Thatcher, H H Wan, R Swindell, et al.
Tubercle|March 1, 1983
Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillusM T Moulsdale, J M Harper, G N Thatcher, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2000
Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenograftsM R Middleton, J Kelly, S Goodger, et al.
Melanoma Research|August 1, 1995
Dacarbazine and interferon-alpha 2a in advanced malignant melanoma: high response rate and prolongation of response duration occur in different patient subpopulationsD C Betticher, S M Lee, C Morris, et al.
British Journal of Cancer|August 14, 1998
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancerG C Jayson, M Middleton, S M Lee, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1986
Corynebacterium parvum followed by chemotherapy (actinomycin D and DTIC) compared with chemotherapy alone for metastatic malignant melanomaN Thatcher, J Wagstaff, A Mene, et al.
Histopathology|January 25, 2006
Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published dataJ E King, N Thatcher, C A C Pickering, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancerH Gurney, E S de Campos, D Dodwell, et al.
Pageof 29

Showing results (121-130 of 289) with videos related to

Sort By:
Pageof 29
Clinical Transplantation|April 1, 1995
Primary varicella in adult renal transplant recipients: a report of three cases plus a review of the literatureA P Parnham, J P Flexman, B M Saker, et al.
Developmental Neuroscience|January 1, 1993
Studies on metabolic regulation using NMR spectroscopyH Bachelard, R Badar-Goffer, O Ben-Yoseph, et al.
International Journal of Immunopharmacology|January 1, 1982
Effects of diphenylhydantoin on killer cell activity and other immunological functions. A sequential study including the interaction of Corynebacterium parvum in melanoma patientsN Thatcher, H H Wan, R Swindell, et al.
Tubercle|March 1, 1983
Infection by Mycobacterium haemophilum, a metabolically fastidious acid-fast bacillusM T Moulsdale, J M Harper, G N Thatcher, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2000
Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenograftsM R Middleton, J Kelly, S Goodger, et al.
Melanoma Research|August 1, 1995
Dacarbazine and interferon-alpha 2a in advanced malignant melanoma: high response rate and prolongation of response duration occur in different patient subpopulationsD C Betticher, S M Lee, C Morris, et al.
British Journal of Cancer|August 14, 1998
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancerG C Jayson, M Middleton, S M Lee, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1986
Corynebacterium parvum followed by chemotherapy (actinomycin D and DTIC) compared with chemotherapy alone for metastatic malignant melanomaN Thatcher, J Wagstaff, A Mene, et al.
Histopathology|January 25, 2006
Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published dataJ E King, N Thatcher, C A C Pickering, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancerH Gurney, E S de Campos, D Dodwell, et al.
Pageof 29